Editors' ChoiceANXIETY DISORDERS

Enhancing cognitive behavioral therapy: Is the finish line in sight?

See allHide authors and affiliations

Science Translational Medicine  01 Mar 2017:
Vol. 9, Issue 379, eaam9857
DOI: 10.1126/scitranslmed.aam9857

You are currently viewing the abstract.

View Full Text

Abstract

Augmentation of cognitive behavioral therapy with D-cycloserine (DCS) for anxiety disorders results in a small decrease in symptom severity.

View Full Text